Welgene Biotech Co., Ltd.(TW:6661)
NT$16.000.00 (0.00%)
TW:6661
Welgene Biotech Co., Ltd. Revenue
NT$16.00
At close:0.00 (0.00%)
Welgene Biotech Co., Ltd. (6661) Revenue
Welgene Biotech Co., Ltd. Revenue
Welgene Biotech Co., Ltd. had a revenue of 107.21M in the quarter ending Jun 30, 2026, with 27.99%. This bring the company's revenue in the last twelve months to 398.92M, Increased 4.48%. In the fiscal year ending Dec 31, 2025, Welgene Biotech Co., Ltd. had annual revenue of 375.94M with 16.55% growth.
- Revenue (ttm)
- 398.92M
- Revenue Growth
- 15.25%
- P/S Ratio
- 0.99
- Revenue/Employee
- TWD 4,699,250
- Employees
- 80
- Market Cap
- TWD 372.87M
Revenue Chart
Welgene Biotech Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 375.94M | 53.39M | 16.55% |
| Dec 31, 2024 | 322.55M | 42.00M | 14.97% |
| Dec 31, 2023 | 280.55M | -41.35M | -12.85% |
| Dec 31, 2022 | 321.90M | 9.25M | 2.96% |
| Dec 31, 2021 | 312.65M | -85.45M | -21.46% |
| Dec 31, 2020 | 398.10M | -19.36M | -4.64% |
| Dec 31, 2019 | 417.46M | 33.03M | 8.59% |
| Dec 31, 2018 | 384.43M | 58.65M | 18.00% |
| Dec 31, 2017 | 325.78M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.